FDA Panel Supports Genzyme, Isis Drug Mipomersen on 9-6 Vote

A federal advisory panel voted to support the use of mipomersen, a drug that would be marketed by Sanofi’s (SNY, SNY.FR) Genzyme unit to treat a rare form of a disease that causes very high cholesterol. But many panel members said they struggled with their decisions amid concerns about possible …